Anagha Inguva Sheth, PhD
@AnaghaInguva
Followers
299
Following
6K
Media
32
Statuses
610
MD/PhD Student at the University of Colorado interested in heme malignancies and BMT. Stanford bound for IM residency and heme/onc fellowship!
Joined July 2019
So excited, humbled and honored to have my PhD work published in @CD_AACR working with @ElizSMcKenna and the CD team is always an absolute dream. So unbelievably thankful to her and CD for making the process so smooth! @DanPollyea @MariaAmaya_27 @CLJonesLab.
Now online in @CD_AACR: Targeting Acute Myeloid #Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium - by @AnaghaInguva @CraigTJordanLab and colleagues @CUHematology @CUMedicalSchool @CUAnschutz #Venetoclax
6
5
30
RT @SarahSkuli: Chemoresistance of TP53 mutant AML requires the mevalonate byproduct, GGPP, for an induction of an adaptive stress response….
0
4
0
RT @BCD_AACR: Author Ravi Majeti is featured in the Tumor Metabolism Collection. Read his article, IDH1-Mutant Preleukemic Hematopoietic St….
0
2
0
RT @KentsisResearch: A new KRG study led by Sumiko Takao et al @NatureComms uncovers how epigenetic mechanisms control human leukemia stem….
0
8
0
RT @BenHuangLab: Excited to share our preprint (manuscript in review): TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumeni….
0
2
0
RT @Ron_Witteles: @AnaghaInguva So excited to welcome you to @StanfordMedRes & @StanfordDeptMed — you’re part of an absolutely incredible g….
0
3
0
RT @StanfordDeptMed: Match Day 2025 is here! 🎉 . Meet the newest class of interns joining us for their residency at Stanford Department of….
0
12
0
Unbelievably excited for this next step in my career!.
Best day of the year? #Match2025 and the @StanfordMedRes residency #retreat the same day!?!? 🤯 We couldn’t be more excited to welcome this INCREDIBLE 2025-2026 intern class to the @StanfordDeptMed family! Includes 14 MD/PhDs and 11 new members of our #TIP program. Congrats &
1
1
11
RT @Haematologica: The new approach for eradicating leukemic stem cells in blast phase chronic myeloid leukemiainvolves the combination of….
0
15
0
RT @CUCancerCenter: CU Cancer Center member Mathew Angelos (@Mat_Angelos), MD, PhD, is pioneering @CUAnschutz's first entirely home-grown c….
0
3
0
RT @KristiKuhn: Looking to inspire the next generation of.physician-scientists? . The University of Colorado School of Medicine invites ap….
0
4
0
RT @lindemilesphd: Excited to share our first story from the lab (and some good news!) led by the impressive Morgan Drucker @cincychildrens….
0
25
0
RT @AlejoFraticelli: This paper changes everything in the AML field. This is the best model of the most frequent and aggressive acute myelo….
0
31
0
RT @CLachowiez: Our manuscript refining risk prediction for HMA+venetoclax-based treatment in AML is now out in @BloodJournal first edition….
0
26
0
RT @KStegmaier_DFCI: Celebrating Kim's appointment to the National Cancer Advisory Board by the POTUS! Congrats to our fearless leader! . P….
0
2
0
Forever thankful to the @CD_AACR team and @ElizSMcKenna ! .@CUHematology @CUCancerBio @CUDeptMedicine @CU_MSTP.
From the October issue: Targeting Acute Myeloid #Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium @AnaghaInguva @CraigTJordanLab @CUHematology @CUMedicalSchool @CUAnschutz #Venetoclax
0
3
11
RT @PratzKW: The UPENN Leukemia Program is recruiting clinicians for the 2025 academic year in Philadelphia. The leukemia team consists of….
0
6
0
RT @Bailee_Kain: Previous studies have shown self-reported Black patients have inferior treatment and survival outcomes compared to White p….
0
15
0
RT @anandbmdphd: Tremendously proud to share my fellowship work, online today in @NatureMedicine. We tried to understand why CAR T therapy….
0
59
0